Free Trial
→ China ATTACK on American Dollar set for 11/12/2026 (From International Living) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$200.48
-1.4%		$205.40
$149.09
▼
$217.12
$10.41B0.71.63 million shs3.62 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$197.00
+0.3%		$136.67
$22.28
▼
$212.22
$78.44B1.0915.50 million shs37.38 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
+0.12%-3.42%-4.05%+3.04%+35.13%
Moderna, Inc. stock logo
MRNA
Moderna
+4.81%+2.03%+34.99%+156.64%+618.65%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$200.48
-1.4%		$205.40
$149.09
▼
$217.12
$10.41B0.71.63 million shs3.62 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$197.00
+0.3%		$136.67
$22.28
▼
$212.22
$78.44B1.0915.50 million shs37.38 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
+0.12%-3.42%-4.05%+3.04%+35.13%
Moderna, Inc. stock logo
MRNA
Moderna
+4.81%+2.03%+34.99%+156.64%+618.65%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
2.68
Moderate Buy$200.48N/A
Moderna, Inc. stock logo
MRNA
Moderna
2.08
Hold$78.17-60.32% Downside

Current Analyst Ratings Breakdown

Latest MRNA and IBB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2026
Moderna, Inc. stock logo
MRNA
Moderna
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$89.00 ➝ $95.00
9/30/2026
Moderna, Inc. stock logo
MRNA
Moderna
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral ➝ Sell$60.00 ➝ $80.00
9/25/2026
Moderna, Inc. stock logo
MRNA
Moderna
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
9/23/2026
Moderna, Inc. stock logo
MRNA
Moderna
Singular Research logo
Singular Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
9/22/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
9/9/2026
Moderna, Inc. stock logo
MRNA
Moderna
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$81.00
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Sell
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral ➝ Sell$40.00 ➝ $81.00
8/28/2026
Moderna, Inc. stock logo
MRNA
Moderna
CLSA logo
CLSA
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeOutperform
(Data available from 10/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B40.46N/AN/A$22.14 per share8.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$7.99N/AN/AN/A-141.43%-28.30%-19.39%11/5/2026 (Estimated)

Latest MRNA and IBB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$1.10N/AN/AN/A$894.85 millionN/A
7/31/2026Q2 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$2.03-$1.97+$0.06-$1.97$102.93 million$145.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$0.340.17%N/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest MRNA and IBB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/14/2026
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
quarterly$0.01120.02%9/15/20269/15/20269/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
0.09
2.29
2.18

Institutional Ownership

CompanyInstitutional Ownership
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
62.45%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A51.20 millionN/AOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700399.24 million356.12 millionOptionable

Recent News About These Companies

Moderna's Next Test: Manufacturing a Cancer Franchise at Scale
October 8 at 4:48 PM  |  ad-hoc-news.deA
Moderna (MRNA) Gets a Hold from Morgan Stanley
October 8 at 4:48 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MRNA/pressreleases/5070794/moderna-mrna-gets-a-hold-from-morgan-stanley/
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
October 8 at 11:48 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/modernas-nasdaq-100-entry-does-114200473.html
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
October 8 at 9:46 AM  |  zacks.comhttps://www.zacks.com/stock/news/3002774/moderna-s-nasdaq-100-entry-what-does-it-mean-for-the-stock?cid=cs-stocknewsapi-ft-analyst_blog|quick_take-3002774
Company News for Oct 8, 2026
October 8 at 6:47 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/company-news-oct-8-2026-082300220.html
Health rounds: Experimental approach uses AI to eliminate cold storage for mRNA vaccines
October 7 at 11:01 PM  |  msn.comhttps://www.msn.com/en-us/news/other/health-rounds-experimental-approach-uses-ai-to-eliminate-cold-storage-for-mrna-vaccines/ar-AA2dJEPi
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
October 7 at 10:09 PM  |  fool.comhttps://www.fool.com/coverage/better-buy/2026/10/07/axsome-therapeutics-vs-moderna-which-biotech-stock-is-a-better-buy-in-2026/
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets
October 7 at 5:11 PM  |  investopedia.comhttps://www.investopedia.com/market-update-moderna-eli-lilly-lead-healthcare-stocks-higher-on-a-down-day-for-markets-mrna-lly-12163337
Moderna, Inc. $MRNA Shares Sold by Lake Hills Wealth Management LLC
October 7 at 1:28 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-shares-sold-by-lake-hills-wealth-management-llc-2026-10-07/
Experimental approach uses AI to eliminate cold storage for mRNA vaccines
October 7 at 12:59 PM  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/experimental-approach-uses-ai-eliminate-cold-storage-mrna-vaccines-2026-10-07/
Moderna (MRNA) Could Be 57% Above Fair Value On New COO Appointment
October 7 at 12:59 PM  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/moderna-mrna-could-57-above-071655948.html
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons
October 7 at 12:59 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cphi-2026-moderna-builds-covid-144314110.html
Tempus Announces Multi-Year Collaboration with Moderna and Merck
October 7 at 12:59 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tempus-announces-multi-collaboration-moderna-123000008.html
Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, Morgan Stanley Analyst Says
October 7 at 10:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-moderna-nasdaq-mrna-stock-price-expected-to-rise-morgan-stanley-analyst-says-2026-10-07/
Tempus Announces Multi-Year Collaboration with Moderna and Merck
October 7 at 9:00 AM  |  businesswire.comhttps://www.businesswire.com/news/home/20261007586639/en/Tempus-Announces-Multi-Year-Collaboration-with-Moderna-and-Merck/
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
October 6 at 3:03 PM  |  247wallst.comhttps://247wallst.com/investing/2026/10/06/moderna-is-up-545-in-2026-take-profits-now-or-keep-buying/?utm_source=snapi
Promising Healthcare Stocks To Watch Now - October 6th
October 6 at 1:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-healthcare-stocks-to-watch-now-october-6th-2026-10-06/
Biotech Stocks To Keep An Eye On - October 6th
October 6 at 12:02 PM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31092755
Paramount–Warner Bros. deal finally closes: Stocks to watch on Tuesday
October 6 at 11:55 AM  |  finance.yahoo.comhttps://finance.yahoo.com/video/paramount-warner-bros-deal-finally-143143885.html
Moderna (NASDAQ:MRNA) Hits New 12-Month High - What's Next?
October 6 at 11:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31092332
Moderna (NASDAQ:MRNA) Hits New 52-Week High - Time to Buy?
October 6 at 10:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-moderna-nasdaq-mrna-hits-new-52-week-high-time-to-buy-2026-10-06/

New MarketBeat Followers Over Time

Media Sentiment Over Time

iShares Biotechnology ETF stock logo

iShares Biotechnology ETF NASDAQ:IBB

$200.48 -2.86 (-1.41%)
Closing price 04:00 PM Eastern
Extended Trading
$200.40 -0.08 (-0.04%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Moderna stock logo

Moderna NASDAQ:MRNA

$197.00 +0.52 (+0.26%)
Closing price 04:00 PM Eastern
Extended Trading
$195.82 -1.19 (-0.60%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas